PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v9i3.10763ArticleAdvances in Biomimetic Nanotechnology for Triple-Negative Breast Cancer Therapyhttps://artdesignp.com/journal/PAR/9/3/10.26689/par.v9i3.10763MaoLezhang,ZengFuren2025932025-06-05This article systematically reviews the application of biomimetic nanotechnology in targeted therapy for triple-negative breast cancer (TNBC). TNBC poses significant challenges for conventional treatments due to the lack of defined therapeutic targets, chemotherapy resistance, and a complex immunosuppressive microenvironment. Biomimetic nanotechnology, by mimicking the functional properties of biological structures (e.g., cell membranes, exosomes), has significantly enhanced drug delivery efficiency, targeting precision, and anti-tumor immune responses. This review focuses on the design strategies of biomimetic nanocarriers (including cell membrane-coated nanoparticles, engineered exosomes, and biomimetic synthetic materials) and their innovative applications in TNBC therapy: (1) Targeted delivery systems that overcome tumor barriers and reduce systemic toxicity; (2) Photothermal therapy combined with immunomodulation for precise treatment and immune activation; (3) Tumor microenvironment regulation (e.g., vascular normalization, pH neutralization, immunosuppression reversal). Studies demonstrate that biomimetic nanotechnology significantly improves TNBC treatment efficacy through multimodal synergistic mechanisms (e.g., chemo-photothermal-immunotherapy). However, challenges such as scalable production, long-term safety, and personalized adaptation remain for clinical translation. Future research should integrate artificial intelligence for optimized design and dynamic imaging technologies to advance biomimetic nanomedicines toward clinical applications.

Obidiro O, Battogtokh G, Akala EO, 2023, Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook. Pharmaceutics, 15(7): 1796.

So JY, Ohm J, Lipkowitz S, et al., 2022, Triple Negative Breast Cancer (TNBC): Non-genetic Tumor Heterogeneity and Immune Microenvironment: Emerging Treatment Options. Pharmacol Ther, 237: 108253.

Singh DD, Yadav DK, 2021, TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy. Biomedicines, 9(8): 876.

Chen HY, Deng J, Wang Y, et al., 2020, Hybrid Cell Membrane-coated Nanoparticles: A Multifunctional Biomimetic Platform for Cancer Diagnosis and Therapy. Acta Biomater, 112: 1–13.

Lopes J, Lopes D, Pereira-Silva M, et al., 2022, Macrophage Cell Membrane-Cloaked Nanoplatforms for Biomedical Applications. Small Methods, 6(8): e2200289.

Oroojalian F, Beygi M, Baradaran B, et al., 2021, Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy. Small, 17(12): e2006484.

Tong Q, Qiu N, Ji J, et al., 2020, Research Progress in Bioinspired Drug Delivery Systems. Expert Opin Drug Deliv, 17(9): 1269–1288.

Fang R, Gao W, Zhang L, 2023, Targeting Drugs to Tumours Using Cell Membrane-coated Nanoparticles. Nat Rev Clin Oncol, 20(1): 33–48.

Khatoon N, Zhang Z, Zhou C, et al., 2022, Macrophage Membrane Coated Nanoparticles: A Biomimetic Approach for Enhanced and Targeted Delivery. Biomater Sci, 10(5): 1193–1208.

Wang D, Wang S, Zhou Z, et al., 2022, White Blood Cell Membrane-coated Nanoparticles: Recent Development and Medical Applications. Adv Healthc Mater, 11(7): e2101349.

Li Z, Cai H, Li Z, et al., 2023 A Tumor Cell Membrane-coated Self-amplified Nanosystem as a Nanovaccine to Boost the Therapeutic Effect of Anti-PD-L1 Antibody. Bioact Mater, 21: 299–312.

Ning S, Dai X, Tang W, et al., 2022, Cancer Cell Membrane-coated C-TiO2 Hollow Nanoshells for Combined Sonodynamic and Hypoxia-activated Chemotherapy. Acta Biomater, 152: 562–574.

Shao J, Zaro J, Shen Y, 2020, Advances in Exosome-based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate. Int J Nanomedicine, 15: 9355–9371.

Zhao L, Gu C, Gan Y, et al., 2020, Exosome-mediated siRNA Delivery to Suppress Postoperative Breast Cancer Metastasis. J Control Release, 318: 1–15.

Sarkar R, Biswas S, Ghosh R, et al., 2024, Exosome-sheathed Porous Silica Nanoparticle-mediated Co-delivery of 3,3’-Diindolylmethane and Doxorubicin Attenuates Cancer Stem Cell-driven EMT in Triple Negative Breast Cancer. J Nanobiotechnology, 22(1): 285.

Zhang M, Hu S, Liu L, et al., 2023, Engineered Exosomes from Different Sources for Cancer-targeted Therapy. Signal Transduct Target Ther, 8(1): 124.

Zhou X, He C, Liu M, et al., 2021, Self-assembly of Hyaluronic Acid-mediated Tumor-targeting Theranostic Nanoparticles. Biomater Sci, 9(6): 2221–2229.

Zhang W, Yu L, Ji T, et al., 2020, Tumor Microenvironment-responsive Peptide-based Supramolecular Drug Delivery System. Front Chem, 8: 549.

He Q, Chen J, Yan J, et al., 2020, Tumor Microenvironment Responsive Drug Delivery Systems. Asian J Pharm Sci, 15(4): 416–448.

Long Y, Fan J, Zhou N, et al., 2023, Biomimetic Prussian Blue Nanocomplexes for Chemo-photothermal Treatment of Triple-negative Breast Cancer by Enhancing ICD. Biomaterials. 303: 122369.

Ding H, Tan P, Fu S, et al., 2022, Preparation and Application of pH-responsive Drug Delivery Systems. J Control Release, 348: 206–238.

Wu M, Ling W, Wei J, et al., 2022, Biomimetic Photosensitizer Nanocrystals Trigger Enhanced Ferroptosis for Improving Cancer Treatment. J Control Release, 352: 1116–1133.

Li W, Li F, Li T, et al., 2023, Self-actuated Biomimetic Nanocomposites for Photothermal Therapy and PD-L1 Immunosuppression. Front Chem, 11: 1167586.

Gallo J, Villasante A, 2023, Recent Advances in Biomimetic Nanocarrier-Based Photothermal Therapy for Cancer Treatment. Int J Mol Sci, 24(20): 15484.

Geng S, Guo P, Li X, et al., 2024, Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer. ACS Nano,18(12): 8971–8987.

Zhang W, Gong C, Chen Z, et al., 2021, Tumor Microenvironment-activated Cancer Cell Membrane-liposome Hybrid Nanoparticle-mediated Synergistic Metabolic Therapy and Chemotherapy for Non-small Cell Lung Cancer. J Nanobiotechnology, 19(1): 339.

Xiao Y, Zhu T, Zeng Q, et al., 2023, Functionalized Biomimetic Nanoparticles Combining Programmed Death-1/Programmed Death-ligand 1 Blockade with Photothermal Ablation for Enhanced Colorectal Cancer Immunotherapy. Acta Biomater, 157: 451–466.

Wang R, Song W, Zhu J, et al., 2024, Biomimetic Nano-chelate Diethyldithiocarbamate Cu/Fe for Enhanced Metalloimmunity and Ferroptosis Activation in Glioma Therapy. J Control Release, 368: 84–96.

Cao J, Qi J, Lin X, et al., 2021, Biomimetic Black Phosphorus Nanosheet-Based Drug Delivery System for Targeted Photothermal-Chemo Cancer Therapy. Front Bioeng Biotechnology, 9: 707208.

Chan M, Chang Z, Huang C, et al., 2022, Integrated Therapy Platform of Exosomal System: Hybrid Inorganic/Organic Nanoparticles with Exosomes for Cancer Treatment. Nanoscale Horiz, 7(4): 352–367.

Bahmani B, Gong H, Luk B, et al., 2021, Intratumoral Immunotherapy Using Platelet-cloaked Nanoparticles Enhances Antitumor Immunity in Solid Tumors. Nat Commun, 12(1): 1999.

Bhullar AS, Jin K, Shi H, et al., 2024, Engineered Extracellular Vesicles for Combinatorial TNBC Therapy: SR-SIM-guided Design Achieves Substantial Drug Dosage Reduction. Mol Therapy, 32(12): 4467–4481. https://doi.org/10.1016/j.ymthe.2024.09.034

Chowdhury P, Bhusetty Nagesh PK, Hollingsworth TJ, et al., 2022, Coating a Self-assembly Nanoconstruct with a Neutrophil Cell Membrane Enables High Specificity for Triple Negative Breast Cancer Treatment. ACS Appl Bio Mater, 5(9): 4554–4566. https://doi.org/10.1021/acsabm.2c00614

Zhang L, Chen W, Wang X, et al., 2024, Macrophage Membrane-coated Magnetic Nanoparticles Enhance Chemoimmunotherapy via CD163-Targeted Delivery and M1 Polarization. Nano Today, 52: 102122.

Liu H, Cai G, Yuan S, et al., 2024, Platelet Membrane-Camouflaged Silver Metal-organic Framework Biomimetic Nanoparticles for the Treatment of Triple-negative Breast Cancer. Mol Pharm, 21(7): 3577–3590.

Jiang Q, Liu L, Li Q, et al., 2021, NIR-laser-triggered Gadolinium-doped Carbon Dots for Magnetic Resonance Imaging, Drug Delivery and Combined Photothermal Chemotherapy for Triple Negative Breast Cancer. J Nanobiotechnology, 19(1): 64. https://doi.org/10.1186/s12951-021-00811-w

Wang Y, Li X, Zhang Z, et al., 2024, Dual-modality NIR-II Photothermal/Immune Checkpoint Blockade Therapy Using IR792-conjugated Silica Nanoshells. Adv Mater, 36(15): 2311285.

Dong S, Huang Y, Yan H, et al., 2024, Ternary Heterostructure-driven Photoinduced Electron-hole Separation Enhanced Oxidative Stress for Triple-negative Breast Cancer Therapy. J Nanobiotechnology, 22: 240. https://doi.org/10.1186/s12951-024-02530-4

Li J, Qiu Y, Xu C, et al., 2024, Hyaluronic Acid-functionalized Hydrogel Nanocarriers for Dual Targeting of TAMs and VEGF in Triple-negative Breast Cancer. Biomaterials, 310: 122345.

Wang Y, Wang H, Song Y, et al., 2022, IR792-MCN@ZIF-8-PD-L1 siRNA Drug Delivery System Enhances Photothermal Immunotherapy for Triple-negative Breast Cancer Under Near-infrared Laser Irradiation. J Nanobiotechnology, 20: 96. https://doi.org/10.1186/s12951-022-01255-6

Yin H, Xiong G, Guo S, et al., 2019, Delivery of Anti-miRNA for Triple-negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133. Mol Ther, 27(7): 1252–1261. https://doi.org/10.1016/j.ymthe.2019.04.018